Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical (NASDAQ: ISRG ) stock is getting a boost on Friday as investors celebrate approval of da Vinci 5 by the Food and Drug Administration (FDA). Da Vinci 5 is the next generation of Intuitive Surgical's multiport robotic system that has been used in more than 7 million procedures.

ISRG Stock Alert: The FDA Is Giving Intuitive Surgical a Big Boost

Intuitive Surgical stock jumped late Thursday after the company won FDA clearance for its next-generation robotic surgery system, da Vinci 5.

Intuitive Surgical Pops After Winning FDA Clearance For Next-Gen Robotic System

Da Vinci 5 builds on decades of Intuitive technology and millions of robotic procedures Da Vinci 5 builds on decades of Intuitive technology and millions of robotic procedures

Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5

Marriott

Netflix

News Corp

Steel Dynamics

Taiwan Semiconductor Manufacturing

AMERCO

If the market's dramatic shifts this year have left you feeling dizzy, you're not alone – but blue-chip stocks might be the anchor you need to regain stability. Amidst the current rally (bubble?

The Blue-Chip Advantage: 7 Stocks for Investors Who Play to Win

In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $382.99, marking a -1.65% move from the previous day.

Intuitive Surgical, Inc. (ISRG) Declines More Than Market: Some Information for Investors

Becton, Dickinson and Co.

Globus Medical

Medtronic

Smith & Nephew

Stryker

Zimmer Biomet Hlds

There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes.

7 Robotic Surgery Stocks to Buy for the Future of Healthcare

Clearway Energy

Coca-Cola

The US tax refund season brings positive news as the average IRS tax refund, currently at $3,182, reflects a 5.1% increase from last year. Despite a slight dip of 1.7% in the number of tax returns filed the U.S. Internal Revenue Service (IRS) reports a smooth and efficient start to tax filing season.

Refund Riches: 3 Stocks to Buy With Your Tax Windfall

Kratos Defense & Security Solutions

UiPath

With technology evolving at a break-neck pace, robotics emerges at the forefront of innovation, offering transformative potential across many sectors from manufacturing to healthcare. Hence, for those with a forward-thinking approach, betting on the top robotics stocks to buy presents itself as a lucrative long-term investment realm.

The Top 3 Robotics Stocks to Buy in March 2024

The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $400.59, representing a +0.68% change from its previous close.

Intuitive Surgical, Inc. (ISRG) Advances While Market Declines: Some Information for Investors

DexCom

Intuitive Surgical's opportunities in the robotic-assisted surgery market far outweigh its recent issues. DexCom still has a long way to go to make its devices mainstream among diabetes patients worldwide.

Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move

Eli Lilly

Novo Nordisk

Vertex Pharmaceuticals

The Magnificent Seven are stealing the show this year on the market. They're all technology companies -- but there are opportunities elsewhere, too.

These 4 Stocks Are the "Magnificent Seven" of Healthcare

Nintendo

The phrase “value tech stocks” almost seems like an oxymoron—value stocks tend to be stable, mature and slow to grow. On the flip side, even the largest tech stocks like Tesla (NASDAQ: TSLA ) tend to focus on growth at all costs while trading at higher multiples than typically seen in value stocks.

3 Value Tech Stocks Ripe for the Picking

Costco

Lam Research

There's a lot of hype, even euphoria, surrounding the top semiconductor stocks these days, specifically those with exposure to the generative artificial intelligence ( AI ) boom. Undoubtedly, Nvidia (NASDAQ: NVDA ) pulled off yet another impressive quarter, helping lift the broader basket of AI chip stocks and most of the technology sector.

3 Breakout Stocks to Buy BEFORE They Take Flight

Symbotic Inc

Robots have many advantages for companies and for society. Companies are benefitting tremendously from their ability to perform many tasks at a fraction of the cost of humans.

Automation Aces: 3 Top Robotics Stocks to Command Your Portfolio

ABB Ltd.

iRobot

As technology continues to advance at an unprecedented pace, robotics stands at the forefront of innovation. It can revolutionize industries from manufacturing to healthcare.

3 Robotics Stocks That Could Be Multibaggers in the Making: February Edition

Fiverr

Healthcare and the gig economy both represent high-growth industry opportunities for investors. Intuitive Surgical has a resilient business model that has weathered economic thick and thin.

2 Unparalleled Growth Stocks That Are Smart Buys Right Now

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Bulls Look Optimistic About Intuitive Surgical, Inc. (ISRG): Should You Buy?

Intuitive Surgical, Inc. (ISRG) reported earnings 30 days ago. What's next for the stock?

Why Is Intuitive Surgical, Inc. (ISRG) Up 2.8% Since Last Earnings Report?

Merck

Merck owns the best-selling drug in the world and has a plan to replace it once it runs out of patent exclusivity. Intuitive Surgical leads an industry that is difficult to penetrate and has plenty of opportunity for growth ahead.

2 Monster Stocks to Buy Without Any Hesitation

In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $380.23, denoting a +0.69% change from the preceding trading day.

Intuitive Surgical, Inc. (ISRG) Surpasses Market Returns: Some Facts Worth Knowing

Sarcos Technology and Robotics Corp

There are some key robotics stocks for investors to buy in February. This is amid the broader indices such as the Nasdaq making a brief pullback.

3 Millionaire-Maker Robotics Stocks to Buy in February 2024

Equinix

Onto Innovation

Rockwell Automation

Top sectors are tough to pin down in advance. Far more often, we look backward at market performance to identify trends and top sectors.

3 Top Sectors Investment Dollars Are Pouring Into Now: February 2024

Surgical robotics and the rare disease drug market are two rapidly growing areas of healthcare. Intuitive Surgical makes most of its money from recurring revenue, a business model that has held up.

2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now

Teradyne

Zebra Technologies

Robotics has the potential to transform various industries, particularly manufacturing and healthcare, by creating new opportunities for automation and efficiency. The sector could very well be on its way to entering a hyper-growth stage as technological advances continue to make these technologies not only possible but efficient.

The 3 Best Robotics Stocks to Buy in February 2024

Teladoc

Healthcare is seeing explosive growth, providing opportunity for investors. Intuitive Surgical leads in surgical robotics, and its market is only expanding.

News for Intuitive Surgical Stock (ISRG)